Reimbursement of medical costs for IUI and IVF

Reimbursement of medical costs for IUI and IVF

The current Joint Sickness Insurance Scheme (JSIS) rules regarding the reimbursement of medical costs for intra-uterine insemination (IUI) or in vitro fertilisation (IVF) de-facto exclude women couples (and single women), who need medical assistance to create a family.

As Egalité has raised on several occasions to the EC representatives, the European institutions should have a truly inclusive health insurance system, reimbursing IUI and IVF without having to demonstrate a pathology, just like it is the case in many EU Member States, in particular, Belgium (where a significant number of the EU institutions staff lives).

End of 2020, the Comité de Gestion de l’Assurance Maladie (CGAM) decided that its working group on the revision of JSIS rules would propose a review of the chapter related to fertility treatments for adoption by CGAM without waiting for the entire package of rules to be revised.

Discussions are now ongoing within CGAM, and we hope that they will result in the adoption of new rules by end of the year, opening IUI and IVF reimbursement to a larger population.